Insulet
PODD
#1019
Rank
C$26.86 B
Marketcap
$383.00
Share price
3.90%
Change (1 day)
33.64%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.47. In 2022 the company made an earnings per share (EPS) of $0.10 a decrease over its 2021 EPS that were of $0.33.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322208.17%
2022$0.10-69.57%
2021$0.33109.09%
2020$0.16-38.89%
2019$0.26200%
2018$0.08621-113.04%
2017-$0.66-9.8%
2016-$0.73-60.77%
2015-$1.8739.78%
2014-$1.3412.05%
2013-$1.19-23.15%
2012-$1.5510.2%
2011-$1.41-36.36%
2010-$2.21-36.63%
2009-$3.49-29.36%
2008-$4.94-86.74%
2007-$37.28-64.04%
2006-$103.66122.23%
2005-$46.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.90-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.64-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.41-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.24 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.27 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.91 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.80 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA